Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors

Journal of Clinical Oncology

Volumn 13, Issue 9, 1995, Pages 2247-2254

  Heideman, Richard L ^a   Kovnar, Edward H ^b   Kellie, Stewart J ^b   Douglass, Edwin C ^b   Gajjar, Amar J ^b   Walter, Andrew W ^b   Langston, James A ^b   Jenkins, Jesse J ^b   Li, Yulan ^b   Greenwald, Carol ^b   Sanford, Robert A ^b   Kun, Larry E ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; BLOOD TOXICITY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GERM CELL TUMOR; HUMAN; MALE; MEDULLOBLASTOMA; NEUTROPENIA; OTOTOXICITY; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA; TUMOR GROWTH;

EID: 0029156011     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.9.2247     Document Type: Article

References (41)

1. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3:255-268, 1993
2. Tait DM, Thornton-Jones H, Bloom HJG, et al: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469, 1990
3. Evans AE, Jenkin RDT, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990
4. Heideman RL, Packer RJ, Albright LA, et al: Tumors of the central nervous system, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, PA, Lippincott, 1989, pp 505-553
5. Khan AB, D'Souza BJ, Wharam MD, et al: Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 66:2013-2020, 1982
6. Sexauer CL, Khan A, Burger PC, et al: Cisplatin in recurrent pediatric brain tumors: A POG phase II study, a Pediatric Oncology Group study. Cancer 56:1497-1501, 1985
7. Bertolone SJ, Baum ES, Krivit W, et al: A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group. J Neurooncol 7:5-11, 1989
8. Kovnar EH, Kellie SJ, Horowitz ME: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J Clin Oncol 8:330-336, 1990
9. Packer RJ, Sutton LN, Elterman R, et al: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, vincristine chemotherapy. J Neurosurg 81:690-698, 1994
10. Schell MJ, McHaney VA, Green AA, et al: Hearing loss in children and young adults receiving cisplatinum with or without prior cranial irradiation. J Clin Oncol 7:754-760, 1989
11. Bacha DM, Caparros-Sison B, Allen JA: Phase I study of carboplatin (CBDCA) in children with cancer. Cancer Treat Rep 70:865-869, 1986
12. Gaynon PS, Ettinger LJ, Baum ES: Carboplatin in childhood brain tumors: A Children's Cancer Study Group phase II trial. Cancer 66:2465-2469, 1990
13. Allen JC. Walker R, Enrique L, et al: Carboplatin and recurrent childhood brain tumors. J Clin Oncol 5:459-463, 1987
14. Riccardi R, Riccardi A, Di Rocco C, et al: Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors. Cancer Chemother Pharmacol 30:21-24, 1992
15. Dodion P, Sanders C, Georges P, et al: In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin. Cancer Chemother Pharmacol 22:80-82, 1988
16. Friedman HS, Krischer JP, Burger P, et al: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 10:249-256, 1992
17. Tsai CM, Gazdar AF, Venson DJ: Lack of in vitro synergy between etoposide and cis-diaminodichloroplatinum (ii). Cancer Res 49:2390-2397, 1989
18. Schabel FM, Trader MW, Laster WR: Cis-dichlorodiammineplatinum (11): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63:1459-1473, 1979
19. Durand RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro model. Cancer Treat Rep 71:673-679, 1987
20. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 3:457-481, 1958
21. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I. Introduction and design. Br J Cancer 34:585-612, 1976
22. Peto R, Pike MC, Armitage NE, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
23. Marina NM, Rodman J, Shema SJ, et al: Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol 11:554-560, 1993
24. Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 11:598-606, 1993
25. Klastersky J, Sculier JP, Lacroix H, et al: A randomized study comparing cisplatin or curboplatin with etoposide in patients with advanced non small cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 8:1556-1562, 1990
26. Alberts DS, Green S, Hannigan EV, et al: Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol 10:706-717, 1992
27. Taylor AE, Wiltshaw E, Gore ME, et al: Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer. J Clin Oncol 12:2066-2070, 1994
28. Mastrangelo R, Lasorella A, Riccardi R, et al: Carboplatin in childhood medulloblastoma/PNET: Feasibility of an in vivo sensitivity test in an "up-front" study. Med Pediatr Oncol 24:188-196, 1995
29. Loeffler JS, Kretschmar CS, Sallan SE: Pre-irradiation chemotherapy for infants and poor prognosis children with medulloblastoma. Im J Radial Oncol Biol Phys 15:177-181, 1988
30. Castello MA, Clerico A, Giovanni D, et al: High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 12:297-300, 1990
31. Diez B, Monges J, Sackmann Muriel F: Evaluation of cisplatin in children with recurrent brain tumors. Cancer Treat Rep 69:911-913, 1985
32. Mosijczuk AD, Nigro MA, Thomas PR, et al: Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group study. Cancer 72:2755-2762, 1993
33. Pendergrass TW, Milstein JM, Geyer RJ, et al: Eight drugs in one-day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5:1221-1231, 1987
34. Friedman HS, Mahaley S, Schold SC, et al: Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery 18:335-340, 1986
35. McIntosh S, Chen M, Sartain PA: Adjuvant chemotherapy for medulloblastoma. Cancer 56:1316-1319, 1985
36. Allen JC, Helson L: High dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749-756, 1981
37. Allen JC, Helson L, Jareb G: Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified phase II trial. Cancer 52:2001-2006, 1983
38. Siena A, Castro-Malaspina H, Gulati SC, et al: Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood 65:655-662, 1985
39. Mulhern RK, Horowitz ME, Kovnar EH, et al: Neurodevelopmental status of infants and young children treated for brain tumors with preirradiation chemotherapy. J Clin Oncol 7:1660-1666, 1989
40. Geyer RJ, Zeltzer PM, Boyett JM, et al: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 12:1607-1615, 1994
41. Duffner PK, Horowitz ME, Krisher JP, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993